NCT00323817已完成2 期
To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia
Zeria Pharmaceutical1 个研究点 分布在 1 个国家目标入组 282 人开始时间: 2006年4月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 282
- 试验地点
- 1
- 主要终点
- Global subject Outcome Assessment
研究概览
简要总结
To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects presenting diagnosis of FD as defined by the Rome II
- •Subjects presenting postprandial fullness and/or Early satiety should be the most bothersome symptom
排除标准
- 未提供
结局指标
主要结局
Global subject Outcome Assessment
时间窗: 12 month
次要结局
- Individual symptom(12 month)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
To Evaluate the Efficacy of Z-338 in Subjects With Functional DyspepsiaFunctional DyspepsiaNCT00333372Zeria Pharmaceutical440
已完成
2 期
The Effects of Z-338 in Subjects With and Without Functional DyspepsiaDyspepsiaNCT00298194Zeria Pharmaceutical52
已完成
3 期
To Verify the Efficacy of Z-338 in Subjects With Functional DyspepsiaFunctional DyspepsiaNCT00761358Zeria Pharmaceutical820
已完成
2 期
The Effect of Z-338 in Subjects With Functional DyspepsiaFunctioanl DyspepsiaNCT00458328Zeria Pharmaceutical40
已完成
3 期
Clinical Trial of DA-5212 in Patients with Functional DyspepsiaFunctional DyspepsiaNCT05842408Dong-A ST Co., Ltd.384